Evidence map›Paper›PMID 30650668›Full record

ReviewGenes2019

m⁶A mRNA Destiny: Chained to the rhYTHm by the YTH-Containing Proteins.

Ditipriya Hazra, Clément Chapat, Marc Graille

Abstract readReview
In one paragraph

Review in Genes, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Article
  2. Dynamic eIF3-S6 Phase Separation Switch Instructed by mAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Roles of m6A modification in neurological diseases.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2022
    Article
  19. Review
  20. mInternational journal of molecular sciences · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ditipriya HazraLaboratoire de Biochimie, Ecole polytechnique, CNRS, Université Paris-Saclay,91128 Palaiseau CEDEX, France. ditipriya.hazra@polytechnique.edu.
Clément ChapatLaboratoire de Biochimie, Ecole polytechnique, CNRS, Université Paris-Saclay,91128 Palaiseau CEDEX, France. clement.chapat@polytechnique.edu.
Marc GrailleLaboratoire de Biochimie, Ecole polytechnique, CNRS, Université Paris-Saclay,91128 Palaiseau CEDEX, France. marc.graille@polytechnique.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The control of gene expression is a multi-layered process occurring at the level of DNA, RNA, and proteins. With the emergence of highly sensitive techniques, new aspects of RNA regulation have been uncovered leading to the emerging field of epitranscriptomics dealing with RNA modifications. Among those post-transcriptional modifications, N6-methyladenosine (m6A) is the most prevalent in messenger RNAs (mRNAs). This mark can either prevent or stimulate the formation of RNA-protein complexes, thereby influencing mRNA-related mechanisms and cellular processes. This review focuses on proteins containing a YTH domain (for YT521-B Homology), a small building block, that selectively detects the m6A nucleotide embedded within a consensus motif. Thereby, it contributes to the recruitment of various effectors involved in the control of mRNA fates through adjacent regions present in the different YTH-containing proteins.

Indexed as

RNA Processing, Post-TranscriptionalAdenosineAnimalsHumansNerve Tissue ProteinsRNA, MessengerRNA Splicing FactorsAdenosineNerve Tissue ProteinsN-methyladenosineRNA, MessengerRNA Splicing FactorsYTHDC1 protein, humanepitranscriptomicsm6A readersmRNA methylationYTH domain

Identifiers

PMID30650668
PMCPMC6356822

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.